Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

2.

Asymptomatic or Minimally Symptomatic Myelofibrosis

3.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

4.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

5.

Glofitamab Regimen Improves Survival in DLBCL


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot